Press release
Neuropathic Pain Market reached US$7.76 billion in 2023 and is expected to reach US$14.97 billion by 2031 - Pfizer Inc., AdvaCare Pharma, Eli Lilly and Company.
Neuropathic Pain Market
Neuropathic Pain Market analysis, according to DataM Intelligence, offers more than just an overview, it investigates the underlying aspects of the sector. The study provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Get a Free Sample PDF copy of the report - https://datamintelligence.com/download-sample/neuropathic-pain-market
The Neuropathic Pain market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.
Neuropathic pain arises from damage or dysfunction in the nervous system, often described as burning, stabbing, or tingling sensations. Common causes include diabetes, nerve injuries, multiple sclerosis, and chemotherapy. Treatment typically involves medications like anticonvulsants, antidepressants, or nerve blocks, alongside physical therapy. Its complex nature requires a tailored approach to pain management.
Forecast Growth Projected:
The Global Neuropathic Pain Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Neuropathic Pain Market:
Pfizer Inc., AdvaCare Pharma, Eli Lilly and Company., Vertex Pharmaceuticals, Abbott, Medtronic, Nevro Corp., Grünenthal, Teva Pharmaceuticals Inc., and Sun Pharmaceutical Industries Ltd.
Segment Covered in the Neuropathic Pain Market:
By Type: Diabetic Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Post-Herpetic Neuralgia, Trigeminal Neuralgia, Spinal Stenosis, Others.
By Treatment Type: Drug Class, Devices.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Industry Development:
In November 2024, Grünenthal announced that its U.S. subsidiary, Averitas Pharma, Inc., has successfully completed recruitment for the Phase III clinical trial called AV001. This trial aims to evaluate the efficacy, safety, and tolerability of QUTENZA (capsaicin) 8% topical system for treating post-surgical neuropathic pain (PSNP). If the trial results are positive, they could potentially support an extension of QUTENZA's label in the U.S. market, further expanding its therapeutic use.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=neuropathic-pain-market
Regional Break out:
The global Neuropathic Pain Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Neuropathic Pain manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Neuropathic Pain in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Speak to Our Senior Analyst and Get Customization in the report as per your requierments: https://datamintelligence.com/customize/neuropathic-pain-market
Frequently asked questions:
➠ What is the global sales value, production value, consumption value, import and export of Neuropathic Pain market?
➠ Who are the global key manufacturers of the Neuropathic Pain Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?
➠ What are the Neuropathic Pain market opportunities and threats faced by the vendors in the global Neuropathic Pain Industry?
➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➠ What focused approach and constraints are holding the Neuropathic Pain market?
➠ What are the different sales, marketing, and distribution channels in the global industry?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuropathic Pain Market reached US$7.76 billion in 2023 and is expected to reach US$14.97 billion by 2031 - Pfizer Inc., AdvaCare Pharma, Eli Lilly and Company. here
News-ID: 3821619 • Views: …
More Releases from DataM Intelligence 4market Research LLP
United States Intravenous Anticoagulants Market to Reach USD 20.1 Billion by 203 …
The Intravenous Anticoagulants Market is anticipated to reach at a high CAGR during the forecast period.
The Intravenous Anticoagulants market focuses on medications administered through IV to prevent or treat blood clots. These anticoagulants, such as heparin and direct thrombin inhibitors, are essential in managing conditions like deep vein thrombosis, pulmonary embolism, and during surgeries to reduce clotting risks. The market is driven by the rising prevalence of cardiovascular diseases, advancements…
United States Biorational Pesticides Market to Reach US$ 18.85 Billion by 2031, …
Global Biorational Pesticides Market reached US$ 6.12 billion in 2023 and is expected to reach US$ 18.85 billion by 2031, growing with a CAGR of 15.1% during the forecast period 2024-2031.
Biorational Pesticides Market includes natural or minimally toxic pesticides derived from microbes, plant extracts, or biochemical agents. Growth is driven by sustainable agriculture, regulatory restrictions on chemical pesticides, and organic farming trends. Applications include pest control in fruits, vegetables, and…
United States Orthopedic Software Market to Reach USD 530.31 Million by 2031, Gr …
The Orthopedic Software Market is valued at a significant CAGR during the forecast period (2024-2031).
Orthopedic software is specialized technology used in healthcare to manage, diagnose, and treat musculoskeletal disorders and injuries. This software helps orthopedic surgeons with patient data management, preoperative planning, surgical navigation, and post-operative care. It provides tools for imaging, such as X-rays and MRIs, to assist in diagnosing bone fractures, joint issues, and other orthopedic conditions. The…
United States Hydrotreating Catalysts Market to Reach USD 1.74 Billion by 2031, …
Global Hydrotreating Catalysts Market reached US$ 1,284.2 million in 2023 and is expected to reach US$ 1,735.5 million by 2031, growing with a CAGR of 4.0% during the forecast period 2024-2031.
Hydrotreating Catalysts Market involves catalysts used in refining petroleum to remove sulfur, nitrogen, and impurities. Growth is driven by fuel quality regulations, refinery upgrades, and cleaner fuel demand. Catalysts improve efficiency, yield, and environmental compliance. Refineries and chemical plants are…
More Releases for Neuropathic
Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which…
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others.
The Neuropathic Ocular Pain market…
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would…
Global Neuropathic Pain Market Research Report Forecast to 2023
Neuropathic Pain Market 2020 comprises a detailed survey of the Neuropathic Pain Market size, share, trends, extension, consumption, and share, segments, application and Forecast 2025.
Global "Neuropathic Pain" Market 2020-2025 Report contains all demographic as well as analytical data regarding market review, growth, demand, and budget analysis. The report mainly highlights the significant trends of the Neuropathic Pain market in terms of thriving companies, business methods, product values and pricing, revenue,…
